Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech graveyard
Biotech
B-cell therapy biotech Walking Fish closes down
Walking Fish CEO Rusty Williams said the biotech was on the precipice of raising more capital before a key internal investor backed out.
Max Bayer
May 7, 2024 5:30pm
Ampio prepares to wind down after final therapeutic dream dies
Mar 26, 2024 9:01am
SQZ opts for liquidation, $11.8M asset fire sale to Stemcell
Mar 1, 2024 10:20am
ObsEva winds down and lays off staff as money, options run out
Feb 28, 2024 4:51am
Ampio’s last shot at success fizzles out in preclinical stage
Feb 15, 2024 7:10am
Roivant's Hemavant bet winds down after cutting ex-Eisai drug
Feb 13, 2024 2:01pm